Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002020509 - MEDICAMENTS AGAINST VIRAL INFECTIONS

Publication Number WO/2002/020509
Publication Date 14.03.2002
International Application No. PCT/EP2001/009772
International Filing Date 24.08.2001
Chapter 2 Demand Filed 01.03.2002
IPC
C07D 311/96 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
311Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
96spiro-condensed with carbocyclic rings or ring systems
C07D 405/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
C07D 491/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/-C07D459/290
02in which the condensed system contains two hetero rings
10Spiro-condensed systems
C07D 493/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
493Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
02in which the condensed system contains two hetero rings
10Spiro-condensed systems
CPC
C07D 311/96
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
311Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
96spiro-condensed with carbocyclic rings or ring systems
C07D 405/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
04directly linked by a ring-member-to-ring-member bond
C07D 491/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
02in which the condensed system contains two hetero rings
10Spiro-condensed systems
C07D 493/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
493Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
02in which the condensed system contains two hetero rings
10Spiro-condensed systems
Applicants
  • BAYER AKTIENGESELLSCHAFT [DE]/[DE] (AllExceptUS)
  • NIKOLIC, Susanne [DE]/[DE] (UsOnly)
  • BARTEL, Stephan [DE]/[DE] (UsOnly)
  • BRANDS, Michael [DE]/[DE] (UsOnly)
  • NIEWÖHNER, Ulrich [DE]/[DE] (UsOnly)
  • PAESSENS, Arnold [DE]/[DE] (UsOnly)
  • GRAEF, Erwin [DE]/[DE] (UsOnly)
  • SCHLEMMER, Karl-Heinz [DE]/[DE] (UsOnly)
  • HENNINGER, Kerstin [DE]/[DE] (UsOnly)
  • ENDERMANN, Rainer [DE]/[DE] (UsOnly)
  • WEBER, Olaf [DE]/[US] (UsOnly)
  • KOLETZKI, Diana [DE]/[DE] (UsOnly)
Inventors
  • NIKOLIC, Susanne
  • BARTEL, Stephan
  • BRANDS, Michael
  • NIEWÖHNER, Ulrich
  • PAESSENS, Arnold
  • GRAEF, Erwin
  • SCHLEMMER, Karl-Heinz
  • HENNINGER, Kerstin
  • ENDERMANN, Rainer
  • WEBER, Olaf
  • KOLETZKI, Diana
Common Representative
  • BAYER AKTIENGESELLSCHAFT
Priority Data
100 43 791.506.09.2000DE
100 54 932.206.11.2000DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) ARZNEIMITTEL GEGEN VIRALE ERKRANKUNGEN
(EN) MEDICAMENTS AGAINST VIRAL INFECTIONS
(FR) MEDICAMENT POUR LUTTER CONTRE DES MALADIES VIRALES
Abstract
(DE)
Chromanonderivate sind hochwirksame antivirale Mittel. Kombinationen von Chromanonen und/oder Chromanolen mit HBV-Polymerase-Inhibitoren, HBV-DNA- bzw. HBV-core-Protein-Inhibitoren und/oder Isoxazolen und gegebenenfalls Interferon hemmen die Vermehrung von HBV-Viren besser als bislang bekannte Mittel.
(EN)
The invention relates to chromanone derivatives which are highly active anti-viral agents. Combinations of chromanones and/or chromanoles with HBV polymerase inhibitors, HBV-DNA- or HBV-core protein inhibitors and/or isoxazoles and optionally interferon inhibit the multiplication of the HBV virus in a better manner than hither to discovered agents.
(FR)
Des dérivés de chromanone sont des agents antiviraux hautement efficaces. Des combinaisons de chromanones et/ou de chromanoles avec des inhibiteurs de la polymérase du HBV, des inhibiteurs de la protéine du HBV-de l'ADN voire des inhibiteurs de la protéine du noyau HBV et/ou des isoxazoles, ainsi qu'éventuellement avec l'interféron inhibent mieux la multiplication des virus HBV que les agents connus jusqu'à présent.
Also published as
Latest bibliographic data on file with the International Bureau